Company / R&D per Share
Unicycive Therapeutics, Inc. R&D per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.37
FY2024
5-year range
$0.37 / $0.82
FY2022-FY2024
Trend
-54.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.41 to $0.37 over the past 2 years.
Based on SEC 10-K filings.
0.37 in FY2024.
Declined from $0.41 to $0.37 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share decreased 54.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.37 | -54.5% |
| FY2023 | $0.82 | +101.4% |
| FY2022 | $0.41 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026